Skip to Content

Drug Interactions between B-Nexa and tiludronate

This report displays the potential drug interactions for the following 2 drugs:

  • B-Nexa (calcium/folic acid/ginger/pyridoxine)
  • tiludronate

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

calcium phosphate, tribasic tiludronate

Applies to: B-Nexa (calcium / folic acid / ginger / pyridoxine) and tiludronate

Tiludronate and calcium phosphate, tribasic should not be taken orally at the same time. Products that contain magnesium, aluminum, calcium, iron, and/or other minerals may interfere with the absorption of tiludronate into the bloodstream and reduce its effectiveness. You should take calcium phosphate, tribasic at least 2 hours before or 2 hours after the tiludronate dose. Talk to a healthcare professional if you are not sure whether a product contains something that could potentially interact with your medication or if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Moderate

tiludronate food

Applies to: tiludronate

Food significantly decreases the levels of tiludronate. Tiludronate should be administered on an empty stomach with 6 to 8 ounces of plain water at least 2 hours before or 2 hours after food. This will make it easier for your body to absorb the medication.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide